Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Free Cash Flow (2022 - 2025)

Neuraxis (NRXS) has disclosed Free Cash Flow for 4 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 10.34% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.5 million through Dec 2025, down 5.52% year-over-year, with the annual reading at -$6.5 million for FY2025, 5.52% down from the prior year.
  • Free Cash Flow hit -$1.9 million in Q4 2025 for Neuraxis, down from -$1.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$204315.0 in Q4 2022 to a low of -$2.8 million in Q3 2023.
  • Historically, Free Cash Flow has averaged -$1.5 million across 4 years, with a median of -$1.5 million in 2025.
  • Biggest five-year swings in Free Cash Flow: crashed 1194.86% in 2023 and later surged 50.44% in 2024.
  • Year by year, Free Cash Flow stood at -$204315.0 in 2022, then plummeted by 1194.86% to -$2.6 million in 2023, then surged by 33.54% to -$1.8 million in 2024, then decreased by 10.34% to -$1.9 million in 2025.
  • Business Quant data shows Free Cash Flow for NRXS at -$1.9 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.5 million in Q2 2025.